Abstract Background/purpose: Volatile anesthetics can produce toxic metabolites and lead to postoperative renal or hepatic dysfunction. The aim of this retrospective study is to compare the changes in renal and hepatic function after general anesthesia using two different volatile anesthetics in prolonged surgery for oral malignancy. Materials and methods: Patients anesthetized by desflurane or sevoflurane in prolonged surgery (>10 hours) for oral malignancy during past 18 months were included. Common biomarkers such as blood urea nitrogen, serum creatinine, serum aspartate aminotransferase (AST), alanine aminotransferase (ALT) in postoperative week (POW) 1, 2, and 3 were the primary outcomes. The mean values and the incidence of abnormality of these biochemical markers were also compared. Results: In this study, 21 and 26 patients receiving desflurane and sevoflurane anesthesia, respectively, were included. Blood urea nitrogen and creatinine levels were not significantly different between the two groups. There was a 2.1-fold and a 3-fold increase in AST in POW1 in the desflurane and sevoflurane groups, respectively. The incidence of marked elevation in AST (greater than 100 IU/L) was significantly higher in the sevoflurane group in POW1. There was a 1.9-fold and a 3.2-fold increase in ALT in POW2 in the desflurane and sevoflurane groups, respectively. The incidence of marked elevation in ALT was significantly higher in the sevoflurane group in POW2. * Corresponding author. Department of Anesthesiology, National Taiwan University Hospital, 4F, Chung-Shan South Road, Taipei 100, Taiwan.
Introduction
Volatile halogenated anesthetics have remained the mainstay of general anesthesia for decades, but these drugs are notorious for their ability to cause varying degrees of hepatic and renal dysfunction. Liver damage ranging from mild increases in serum aminotransferases to massive hepatic necrosis can occur after halothane anesthesia. 1 Methoxyflurane anesthesia can lead to renal tubular degeneration and microlithiasis, contributing to the occurrence of postoperative renal failure. 2 The generation of toxic metabolitesdtrifluroacetyl acid (TFA) and inorganic fluoride ionsdhas been implicated in the occurrence of postoperative organ toxicities after general anesthesia. 1 As a consequence, the two anesthetics have been less frequently used in recent years.
Desflurane and sevoflurane both have a low fat solubility and therefore provide a fast onset and recovery from anesthesia. 3 Desflurane is metabolized by hepatic cytochrome P450 2E1, producing TFA, which is the same ensuing toxic product after halothane metabolism. However, the rate of metabolism in desflurane is far lower than that in halothane (0.01% for desflurane vs. 20% for halothane). 1 Consequently, desflurane is considered to be much less toxic than halothane in theory. Nonetheless, sporadic case reports of desflurane-induced hepatic injury are still found in the literature. 4 Sevoflurane appears to have negligible effect on hepatic function because its metabolism does not produce toxic TFA. 1 Even so, sevoflurane-induced hepatic failure has also been reported. 5 Sevoflurane has also been considered as nephrotoxic because it reacts with the basecontaining carbon dioxide absorber in the circuit of the ventilator and produces compound A, which shows explicitly renal toxicity in rodents. 1, 3 In addition, the production of inorganic fluoride after sevoflurane metabolism may aggravate postoperative renal dyfunction. 1, 3 Although desflurane and sevoflurane have been administered to millions of people without apparent organ toxicity, most of these patients are anesthetized only for a moderate duration. Based on the assumption that the severity of the organ toxicity can increase with a longer duration of anesthesia, the changes in hepatic and renal functions after prolonged exposure to volatile anesthetics could become more obvious and thus deserve to be examined. Several studies were done to compare hepatic or renal effects using different modes of delivering sevoflurane or compare sevoflurane with isoflurane in prolonged anesthesia.
6e10 However, sevoflurane and desflurane have not been specifically compared in this regard.
The surgery for oral malignancy usually takes a longer time than most other types of surgery because of the need for meticulous tumor resection and complex reconstructive procedures done at the same time. Sevoflurane and desflurane are both suitable in anesthesia for such prolonged surgery considering the character of fast recovery. We are particularly interested in the effect of different anesthetics on the changes in common clinical biomarkers of renal and hepatic functions in order to define a more judicious selection of anesthetic technique in prolonged anesthesia for oral cancer surgery. Therefore, we conducted this retrospective cohort study to compare the changes in biomarkers for hepatic and renal function after anesthesia using either sevoflurane or desflurane in prolonged surgery for oral malignancy within the setting of a university medical center.
Materials and methods
Because of the retrospective nature of this study, it was granted an exemption for obtaining written consent forms by the institutional review board of our hospital. The charts of patients receiving surgery for oral malignancy (including tumor removal and reconstructive procedure) during the past 18 months in a university medical center were included for review. Only those with an operation time longer than 10 hours were included. Those with preexisting hepatic or renal dysfunction, defined as an abnormal value in any one of the preoperative biochemical markers [institutional normal range: aspartate aminotransferase (AST) or alanine aminotransferase (ALT) less than 40 IU/L; blood urea nitrogen (BUN) and serum creatinine below 24 and 1.3 mg/dL, respectively], were excluded from analysis. Patients who were anesthetized by volatile anesthetics other than desflurane or sevoflurane were also excluded.
No premedication was given to any of the patients. The induction regimen included intravenous propofol (2e2.5 mg/kg), fentanyl (2e2.5 mg/kg), and cisatracurium (1.5e2 mg/kg). Tracheal intubation was performed either by direct laryngoscope or with the aid of fiberoptic guidance as indicated. The choice of sevoflurane or desflurane for maintenance of general anesthesia was up to the anesthetist's decision on the spot. Fresh gas flow was a mixture of air and oxygen (both at a flow rate of 0.5 L/min, total flow rate 1 L/min) as a routine during stable conditions in our hospital. The concentrations of volatile anesthetics were maintained between 1 and 2 minimum alveolar concentrations throughout the operation. Boluses of fentanyl or cisatracurium were added for analgesia or muscle relaxation as necessary. Transfusion and volume therapy were started as per the decision of the anesthesiologist in charge. Ephedrine or dopamine infusion was started to maintain proper blood pressure if necessary.
It is a routine matter to check the hematological and biochemical profiles on a weekly basis postoperatively in the majority of these patients. Therefore, we traced the biomarkers for renal function (including BUN and serum creatinine) and hepatic function (mainly serum AST and ALT) in postoperative week (POW) 1, 2, and 3 while reviewing the medical records. Albumin, total bilirubin, major ions in serum, and hematological profiles were also collected at the same time points. When a value of a biomarker at any time point was missing and could not be found in the charts, it was excluded from comparison at that time point. Immediate postoperative data [1 st postoperative day (POD1)] were retrieved when possible. The normal ranges of these biomarkers are as aforementioned. The number of an elevation in AST or ALT was defined as the total case number with a value greater than 40 IU/L. A marked elevation in AST/ALT level refers to a value greater than 100 IU/L.
All data were expressed as mean AE standard deviation or percentage. The range or case number was shown in the table in some variables. Categorical variables were compared using the chi-square test or Fisher exact test where appropriate. Continuous variables in the demographic data were compared using the Student t test. Changes in the biomarkers or hematological data were compared to their respective preoperative values using a paired t test. The difference was regarded as statistically significant when the P value was less than 0.05.
Results
A total of 69 patients underwent prolonged general anesthesia in surgery for oral malignancy in our hospital during the past 18 months. Seven cases were excluded because isoflurane was used for maintenance of anesthesia. Fifteen cases were excluded because of abnormal preoperative liver function. None of the patients were found to have abnormal renal function preoperatively. Finally, 47 cases were included for analysis. Twenty-one patients received desflurane for maintenance of anesthesia, whereas 26 patients received sevoflurane. Patients anesthetized with sevoflurane and desflurane were similar with respect to age, sex, body weight, body height, ASA (American Society of Anesthesiologists) physical status, duration of anesthesia, intraoperative fluid supplement or transfusion, urine output, estimated blood loss, fentanyl dose, or inotropic use (Table 1) .
With regard to the changes in biochemical markers of renal function, serum BUN was slightly but significantly increased 1 week after operation (POW1) compared to the preoperative values only in the desflurane group. However, none of the values exceeded the upper limit of the normal range (24 mg/dL) in POW1. There was no significant change in BUN levels at other time points in both groups. By contrast, serum creatinine was significantly decreased on POW1, POW2, and POW3 in both groups. There was no significant difference in BUN or creatinine levels between the two groups at all time points (Table 2) . Serum AST, ALT, total bilirubin, and albumin were used to determine the changes in postoperative liver function and are shown in Tables 3 and 4 . The serum AST level appeared unchanged on POD1, but was significantly increased from preoperative values in POW1 and POW2 regardless of the choice of anesthetics. The increase in AST was more remarkable in POW1: there was a 2.1-fold increase in AST values in the desflurane group and a 3-fold increase in the sevoflurane group. Although the fold of increase was greater in the sevoflurane group, we were unable to show a significant difference in AST values between the two groups. Approximately half of the patients had an elevation in AST value in POW1 in both groups. However, five patients in the sevoflurane group had a marked elevation in AST at this time point, in contrast to none in the desflurane group (P < 0.05). AST values returned to the preoperative level in POW3 in both groups. The serum ALT was significantly increased from preoperative values in POW1 and POW2 in both groups. Unlike AST, the increases in ALT peaked in POW2: there was a 1.9-fold increase in the desflurane group and a 3.2-fold increase in the sevoflurane group. The ALT value in POW2 was significantly higher in the sevoflurane group than in the desflurane group (P < 0.05). Moreover, both the incidences of an elevation (>40 IU/L) or a marked elevation in ALT (>100 IU/L) in POW2 were significantly higher in the sevoflurane group. The ALT values returned to a level comparable to preoperative values in POW3 in both groups. One patient in the sevoflurane group experienced significant liver dysfunction in POW2 and 3 (AST and ALT values are 399 and 547 IU/L in POW2, respectively). An abdominal sonogram revealed parenchymal liver disease, compatible with the clinical diagnosis of acute hepatitis made by a hepatologist after excluding the possibility of viral insult or other common drug-induced hepatitis. The liver function returned to normal range about 1 month after the operation. There was no such case of persistent hepatic dysfunction in the desflurane group. Serum total bilirubin was significantly increased on POD1, but returned to the preoperative level in POW1, and then decreased in POW2 and POW3 in both groups. Serum albumin was significantly decreased in POW1, POW2, and POW3 compared to the preoperative values in both groups. No significant difference in bilirubin or albumin level was found at all time points between the two groups.
As for the hematological profile, hemoglobin level was significantly decreased through POD1 to POW3 in both groups. The white blood cell count was increased significantly from POD1 to POW2, and then returned to preoperative levels in POW3. Platelet count decreased on POD1, but increased above the preoperative values in POW2 and POW3 in both groups. There was no significant difference between the two groups with regard to the hemotological profile at all time points (Table 5 ).
The changes in major ions in serum are shown in Table 6 . Serum sodium ion concentration decreased significantly in POW1 and POW2 in the desflurane group and in POW2 and POW3 in the sevoflurane group. The incidence of hyponatremia in POW2 was significantly higher in the sevoflurane group. Serum potassium was significantly increased in POW2 in both groups. Yet, the incidence of hyperkalemia was similar. Serum chloride was significantly decreased in POW2 in both groups, but only in the sevoflurane group in POW3. No significant difference in ion concentrations was observed at all time points between the two groups.
Discussion
The hepatic and renal effects after prolonged anesthesia using halogenated volatile anesthetics have been studied in several previous reports. 6e10 Nevertheless, the present study has several unique points. First, the duration of anesthesia was unanimously longer than 10 hours in all cases, unlike that in some previous reports, which included cases with a shorter duration of anesthesia. 9 Second, previous studies only showed the data from several days to 1 week postoperatively. 6,8e10 Our study showed data up to 3 weeks postoperatively. Lastly, we compared the difference between desflurane and sevoflurane anesthesia in this study. Such a difference has not been specifically addressed in those who underwent prolonged anesthesia in the past. The primary results of this study were as follows: (1) prolonged sevoflurane did not produce clinically significant renal injury; (2) transient increases in serum aminotransferases were found after prolonged anesthesia using either sevoflurane or desflurane; such an increase peaked in the 1 st to 2 nd week and mitigated in the 3 rd week postoperatively; (3) postoperative increases in aminotransferases appeared to be higher in those who received sevoflurane than those who received desflurane; the incidence of marked elevation in aminotrasferases was also higher in the sevoflurane group than in the desflurane group.
As aforementioned, inorganic fluoride ions and compound A can cause renal injury after sevoflurane anesthesia, particularly in laboratory animals. However, sevoflurane has been administered to millions of patients without any confirmed report of anesthetic-induced increase in BUN or creatinine postoperatively up to now. 1 The present study also supports the idea that prolonged sevoflurane anesthesia does no harm to the kidney. The lack of sevoflurane-related renal damage can be explained in several ways. Intrarenal fluoride concentration could be lower despite the higher plasma concentrations after sevoflurane anesthesia, rendering it less nephrotoxic. 11 In addition, it is generally believed that a process involving bioactivation by renal b-lyase plays a pivotal role in compound A-induced renal cell damage in rats. 1 The metabolic activity of renal b-lyase is 7e26 times lower in humans than in rats. 12 Taken together, these facts could explain, at least partly, the lack of sevoflurane-related renal toxicity in humans.
The proposed mechanisms of volatile anestheticinduced hepatic dysfunction include: (1) reduced hepatic blood flow during anesthesia, 13 (2) increased cytosolic calcium ion concentration in hepatocytes, 14 and (3) generation of toxic metabolite.
1 TFA has been identified as the hepatotoxic metabolite of desflurane. One of the glutathione S-conjugates of compound A was found to increase liver enzyme and produced centrilobular necrosis in rat liver, 15 and could possibly account for the hepatic dysfunction after sevoflurane anesthesia. In this study, we found that sevoflurane led to more severe hepatic damage compared with desflurane. In another study, desflurane was also found to preserve liver function better than sevoflurane after a moderate duration of anesthesia. 13 The reason for such a phenomenon is not clear because no mechanistic exploration was done in both studies. It was Values are expressed as mean AE standard deviation or number of cases. No. of elevation in AST/ALT level was defined as the total case number having a value greater than 40 IU/L at the time point. Marked elevation in AST/ALT level referred to a value greater than 100 IU/L. *P < 0.05 compared with the corresponding preoperative value. suggested that the differential ability of the two anesthetics to decrease hepatic blood flow might explain their effects on postoperative liver function. 13 Another possible reason is that the S-conjugates of compound A could exert a stronger toxic effect than TFA. In any case, desflurane seems to be a preferable choice in patients receiving anesthesia for prolonged oral cancer surgery.
Although we showed several differences in the changes in hepatic function after prolonged general anesthesia for oral cancer surgery using two different anesthetics, some factors other than the choice of volatile anesthetics could still affect the extent of change in liver function. Concurrent medications, especially antibiotics, could also contribute to the postoperative changes in liver function. However, all antibiotic medications were prescribed following the same protocol in both groups. We also reviewed the charts to rule out the concurrent use of potentially hepatotoxic drugs apart from antibiotics. The differences in liver function between the two groups did not seem to be caused by other concurrent medications. However, elevations in blood AST and ALT levels in some patients could be due to posttransfusion hepatitis. We did not routinely check the hepatitis profile in every patient before or after the operation. Therefore, we could not completely rule out the possibility of posttransfusion hepatitis in all patients. Nonetheless, several reasons prompted us not to consider posttransfusion hepatitis as the major factor to cause the difference in postoperative hepatic injury between the two groups. The incidence of elevated aminotransferases in this study was too high compared with the reported incidence of posttransfusion hepatitis in Taiwan, particularly in the sevoflurane group. 16 The mean peak ALT value in posttransfusion hepatitis (>300 IU/L) was significantly higher than what we found in this study. 16 The average incubation period for posttransfusion hepatitis was reported to be as long as 46 days. There was a significant incidence (60%) of turning into chronic hepatitis in the case of posttransfusion hepatitis. 16 In contrast, liver injury occurred only 1 or 2 weeks after the operation and was usually self-limited and resolved within 1 month in our study. As a matter of fact, the patient with the most prolonged deterioration in liver function in this study did not receive any transfusion during the operation, and serology tests excluded any sign of insult from viral origin (after consulting a hepatologist). In addition, the amount and the case number of transfusion were not different between the two groups. We could not reasonably infer that the difference in postoperative liver function was a result of transfusion. Collectively, we considered that the clinical manifestation in this study could not properly fit posttransfusion hepatitis, and transfusion alone was not sufficient to explain the difference between the two groups. Lastly, this is a retrospective cohort study with a relatively limited case number. Some missing data during the follow-up period make the comparison more difficult. A better-designed prospective, randomized study with adequate case number is expected to confirm the findings of this study.
In conclusion, this study reassured the lack of clinically relevant sevoflurane-related nephrotoxicity after prolonged anesthesia for oral cancer surgery. A transient deterioration in liver function was found after prolonged anesthesia for oral cancer surgery using desflurane or sevoflurane. However, sevoflurane might produce a more severe degree of liver damage than desflurane after prolonged anesthesia. Such a result alerts healthcare personnel that the choice of the anesthetic agent may have an impact on postoperative hepatic function and warrants the need for a more comprehensive study on the hepatic effects of different anesthetic techniques in prolonged oral cancer surgery.
